Effects of HER2 and HER3 on EGFR trafficking and localization - a modelling study

被引：0
|
作者：
Resat, H
Shankaran, H
Wiley, H
机构：
[1] Pacific NW Natl Lab, Computat BioSci Grp, Richland, WA USA
[2] Pacific NW Natl Lab, Div Biol Sci, Richland, WA USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
68
引用
收藏
页码：13A / 13A
页数：1
相关论文
共 50 条
  • [1] Novel agents that downregulate EGFR, HER2, and HER3 in parallel
    Ferreira, Renan Barroso
    Law, Mary Elizabeth
    Jahn, Stephan Christopher
    Davis, Bradley John
    Heldermon, Coy Don
    Reinhard, Mary
    Castellano, Ronald Keith
    Law, Brian Keith
    [J]. ONCOTARGET, 2015, 6 (12) : 10445 - 10459
  • [2] The involvement of EGFR, HER2 and HER3 in the basal cell carcinomas aggressiveness
    Florescu, Diana Elena
    Stepan, Alex Emilian
    Margaritescu, Claudiu
    Ciurea, Raluca Niculina
    Stepan, Mioara-Desdemona
    Simionescu, Cristiana Eugenia
    [J]. ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2018, 59 (02): : 479 - 484
  • [3] HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR?
    Freeman, MR
    [J]. CANCER CELL, 2004, 6 (05) : 427 - 428
  • [4] The immunoexpression of EGFR, HER2 and HER3 in malignant serous ovarian tumors
    Cirstea, Andreea-Elena
    Stepan, Alex Emilian
    Margaritescu, Claudiu
    Zavoi, Roxana Eugenia
    Olimid, Daniel Alin
    Simionescu, Cristiana Eugenia
    [J]. ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2017, 58 (04): : 1269 - 1273
  • [5] Transactivation of HER2 by phosphorylated HER3 and EGFR correlates with clinicopathological end points in HER2 negative NSCLC
    Mohan, Kamlesh
    Dodson, Andrew
    Gosney, John
    Carr, Martin
    Thomas, Andrew
    Womack, Chris
    Jenkins, Martin
    McGuire, Joe
    Walshaw, Martin
    Armour, Alison
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S897 - S898
  • [6] EGFR, HER2, and HER3 Expression in Laryngeal Primary Tumors and Corresponding Metastases
    Qichun Wei
    Liming Sheng
    Yongjie Shui
    Qiongge Hu
    Hans Nordgren
    Jorgen Carlsson
    [J]. Annals of Surgical Oncology, 2008, 15 : 1193 - 1201
  • [7] EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases
    Wei, Qichun
    Sheng, Liming
    Shui, Yongjie
    Hu, Qiongge
    Nordgren, Hans
    Carlsson, Jorgen
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (04) : 1193 - 1201
  • [8] EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases
    Wei, Qichun
    Chen, Lirong
    Sheng, Liming
    Nordgren, Hans
    Wester, Kenneth
    Carlsson, Jorgen
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (03) : 493 - 499
  • [9] Quantifying the effects of co-expressing EGFR and HER2 on HER activation and trafficking
    Shankaran, Harish
    Zhang, Yi
    Opresko, Lee
    Resat, Haluk
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 371 (02) : 220 - 224
  • [10] Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity
    Hanker, Ariella B.
    Brown, Benjamin P.
    Meiler, Jens
    Marin, Arnaldo
    Jayanthan, Harikrishna S.
    Ye, Dan
    Lin, Chang-Ching
    Akamatsu, Hiroaki
    Lee, Kyung-Min
    Chatterjee, Sumanta
    Sudhan, Dhivya R.
    Servetto, Alberto
    Brewer, Monica Red
    Koch, James P.
    Sheehan, Jonathan H.
    He, Jie
    Lalani, Alshad S.
    Arteaga, Carlos L.
    [J]. CANCER CELL, 2021, 39 (08) : 1099 - +
12345